Learn More
Selleck Chemical LLC 3BDO 10mg 890405-51-3 3-benzyl-5-((2-nitrophenoxy) methyl)-dihydrofuran-2(3H)-one

Supplier: Selleck Chemical LLC S831710MG

3BDO, a butyrolactone derivative, could target FKBP1A and activate the mTOR signaling pathway. It inhibits autophagy in HUVECs. 3BDO inhibits oxLDL-induced apoptosis. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.